Search Results

41 - 50 of 86 items :

  • Anatomy and Physiology x
Clear All
High Prevalence of Zinc Deficiency in Rural Nigerian Preschool Children: A Community-Based Cross-Sectional Study

, Saidu Y, Aliyu RU. Serum vitamin A and zinc levels of some preschool children in Sokoto metropolis of Nigeria. Biokemistri 14: 82-87, 2003. 19. Fischer Walker CL, Ezzati M, Black RE. Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur J Clin Nutr 63: 591-597, 2009. 20. Ploysangam A, Falciglia G, Brehm B. Effect of marginal zinc deficiency on human growth and development. J Trop Pediatr 43: 192-198, 1997. 21. Gibson RS. Zinc: the missing link in combating micronutrients malnutrition in developing

Open access
Evaluation of Association Between Q192R and L55M Genetic Polymorphisms of PON1 and Serum Paraoxonase-1 Activity in Healthy Individuals, a Meta-Analysis

References 1. Mackness M, Mackness B. Human paraoxonase- 1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene 67: 12-21, 2015. 2. La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 43: 227-2279, 1988. 3. Shih DM, Gu L, Xia YR et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394: 284-287, 1998. 4. Wei LK, Au A, Menon S et al. Polymorphisms of MTHFR, eNOS, ACE

Open access
Haemoglobin A1c and Iron Deficiency Anaemia our Understanding Through the Decades

and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131): 837-853, 1998. 4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329: 977-986, 1993. 5. American Assocation of Diabetes. Standards of medical care in diabetes. Diabetes Care, 30: S4-S41, 2007. 6. Jeffcoate SL. Diabetes control and complications: the role of

Open access
Modern Approach in Premature Ovarian Failure

, Valetto A. An idic(15) associated with POF (premature ovarian failure): molecular cytogenetic definition of a case and review of the literature. Gene 503: 123-125, 2012. 6. He C, Kraft P, Chen C et al. Genome-wide association studies identify loci associated with age at menarche and age of natural menopause. Nat Genet 41: 724-728, 2009. 7. Nelson LM. Primary ovarian insufficiency. N Engl J Med 360: 606-614, 2009. 8. Bodega B, Porta C, Crosignani PF, Ginelli E, Marozzi A. Mutations in coding region of FOXL2 gene are not a major cause of idiopathic

Open access
One Year Follow-up Results after Sleeve Gastrectomy in Type 2 Diabetes Mellitus Patients with Morbid Obesity

R eferences 1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 15: 1097–1105, 1999. 2. National Heart Lung and Blood Institute. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD, USA: National Heart Lung and Blood Institute, 2000. Accessed at: http://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf 3. Gloy VL, Briel M, Bhatt DL et al. Bariatric surgery versus non-surgical treatment

Open access
Insulin Resistance Markers in Type 1 Diabetes Mellitus

SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 30: 707-712, 2007. 22. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62: 963-970, 2002. 23. Teupe B, Bergis K. Epidemiological evidence for “double diabetes

Open access
Neonatal Diabetes – From Gene Discovery yo Clinical Practice Changes

. 19. Inagaki N, Gonoi T, Clement JP et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170, 1995. 20. Shimomura K. The K(ATP) channel and neonatal diabetes. Endocr J 56: 165-175, 2009. 21. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54: 87-143, 1989. 22. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005. 23. Thomas PM

Open access
New Therapeutic Approaches to Prevent or Delay Beta-Cell Failure in Diabetes

implications - a review. Nutr J 13: 17, 2014. 43. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471, 2007. 44. Koffarnus RL, Wargo KA, Phillippe HM. Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus. Ann Pharmacother 47: 877-885, 2013. 45. Gowda N, Dandu A, Singh J et al. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation

Open access
Efficiency of Michigan Neuropathy Screening Instrument and Nerve Conduction Studies for Diagnosis of Diabetic Distal Symmetric Polyneuropathy

progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 55: 806–812, 2006. 9. Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817–824, 1993. 10. Spallone V, Ziegler D, Freeman R et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27: 639–653, 2011. 11. Perkins BA

Open access
Elevated 1 Hour Glucose During Oral Glucose Tolerance Test- A New Parameter of Impaired Metabolism

R eferences 1. Menke A, Casagrande S, Geiss L et al . Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA 314: 1021–1029, 2015 2. American Diabetes Association . Standards of medical care in diabetes: Prevention or delay of type 2 diabetes. Diabetes Care 39 [Suppl.1]: S36-S38, 2016 3. Abdul-Ghani MA, Abdul-Ghani T, Ali N et al. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31: 1650–1655, 2008. 4. Abdul

Open access